--(BUSINESS WIRE)--Senator Van Hollen will join the leaders of Maryland biotechnology company GlycoMimetics for a tour of the company’s facilities before participating in a roundtable discussion on the economic and societal value of biotech innovation.
Senator Van Hollen will learn more about prospects for, and impediments to, the continued growth of this high-wage industry in Maryland. The Senator also will discuss the potentially significant effects of the federal health care policy and budget debates.
|WHAT:||Tour and Roundtable Discussion at GlycoMimetics|
|WHO:||Maryland Senator Chris Van Hollen|
|Jim Greenwood, President & CEO, BIO|
|Rachel King, CEO, GlycoMimetics, Inc.|
|Other senior leadership from GlycoMimetics|
|WHEN:||Friday, December 8, 2017 from 9:45 am – 11:00 am|
|9708 Medical Center Drive|
|Rockville, MD 20850|
Media requested to RSVP to George Goodno, mailto:email@example.com
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.